13th May 2022 12:49
JPMORGAN ELECT PLC (the 'Company') |
|
Legal Entity Identifier: 549300FIUYKKL39ILD07 | |
THE COMPANY ANNOUNCES THE TEN LARGEST INVESTMENTS IN % OF TOTAL ASSETS As at: 29 April 2022 | |
Managed Growth portfolio |
|
JPMorgan American Inv Trust | 14.5% |
JPM UK Equity Plus C | 8.5% |
JPMorgan Claverhouse Inv Trust | 8.2% |
JPMorgan UK Dynamic C | 6.9% |
JPMorgan US Equity All Capital C | 6.6% |
Finsbury Growth & Income | 5.1% |
Murray Income Trust | 3.8% |
JPMorgan US Value Fund | 3.5% |
JPMorgan US Select Equity C | 3.3% |
Fidelity | 3.3% |
Total | 63.8% |
Managed Income portfolio |
|
Shell | 8.5% |
AstraZeneca | 6.9% |
BP | 4.4% |
GlaxoSmithKline | 4.2% |
OSB | 3.6% |
British American Tobacco | 3.4% |
Glencore | 3.1% |
Rio Tinto | 2.8% |
Barclays | 2.7% |
Computacenter | 2.7% |
Total | 42.2% |
* Based on invested portfolio | |
Name of contact and telephone number for queries: | |
Paul Ainger 0044 207 742 6524 | |
Name of authorised company official responsible for making this notification: | |
Priyanka Vijay Anand 0044 203 493 1504 - Company Secretary | |
Date: 13 May 2022 | |
Related Shares:
JPE.LJPEC.LJPEI.L